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The threshold for detecting a rise in airflow resistance during  
tidal breathing is lower in older patients with COPD than  
in healthy people of similar age
Abstract
Introduction: To investigate whether or not the threshold for subjectively detecting an increase in the resistance to airflow (LDT) 
during tidal breathing at rest rises in older age in patients with COPD, as it does in healthy people and asthmatics in remission.
Material and methods: We conducted an open cross-sectional study of 31 older patients (age 55–89) with COPD and 60 healthy 
volunteers (age 55–86). Inspiratory and expiratory resistive load detection thresholds (ILDT and ELDT respectively) and spirometry 
were measured.
Results: The mean (SD) ILDT was 5.93 (7.02) kPa.s/L in COPD patients, compared to 11.11 (8.47) in healthy people (P < 0.001) 
in the same age range. There was no significant correlation between ILDT and age in the COPD group (r = -0.182, P = 0.326), 
though significant correlation with age was found in healthy people (r = 0.591, P < 0.001). ILDT and ELDT in COPD patients 
correlated significantly with the FEV1/FVC ratio (r = 0.367, P = 0.048 and r = 0.481, P = 0.007 respectively) but not with other 
spirometry indices, height, weight, BMI, oxygen saturation or smoking pack-years. 
Conclusion: LDT during tidal breathing appears to be sensitized, and thereby lower, in older COPD patients, possibly due to altered 
central regulation of the threshold or as a consequence of the effect lung compliance, recoil and volume changes have on afferent 
input from mechano-receptors in COPD. Older COPD patients with good cognition are therefore likely to be as aware of changing 
airways resistance as younger patients and take appropriate therapeutic action. 
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Introduction
In previous studies we showed that the thre-
shold for the subjective detection of an increase 
in an incrementally applied external resistive 
load to airflow (LDT) during tidal breathing rises 
with age in a substantial proportion of healthy 
people and asthmatic patients in remission [1, 
2]. We contended that this had implications for 
elderly patients who might consequently be less 
able to sense the early stages of a relapse in their 
asthma and therefore delay taking appropriate 
action. That argument was consistent with the 
commonplace clinical experience that older 
asthmatics tend to present later than younger 
patients when they are having an exacerbation. 
Following the same logic for the study reported 
in this paper we hypothesized that patients with 
chronic obstructive pulmonary disease (COPD) 
would be expected to exhibit a similar age effect 
unless the chronically high airflow resistance in 
patients with COPD results in an adaptive respon-
se leading to higher detection thresholds across 
the older (above 55 years) age range and thereby 
a loss of the progressive age-related rise seen in 
normal subjects and well-controlled asthmatics 
within the 55 to 80+ age band. This might in turn 
lead to a generally blunted sense of raised airflow 
resistance, one consequence of which could be 
a tendency to under-ventilate in response to ri-
sing resistance and could arguably contribute to 
carbon dioxide retention in some COPD patients 
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[3]. There is some empirical evidence for this 
contention though almost all extant studies have 
been carried out in patients with COPD using 
sequential bronchoconstriction or under dynamic 
external airflow loading conditions [4–6]. During 
induced bronchoconstriction airflow resistance 
rises in relatively large and unpredictable incre-
ments so it is difficult to determine accurately 
the level of airways resistance at which a sensa-
tion of impaired airflow is first felt subjectively. 
Therefore, studies of that type might not provide 
the best insight into the influence of ageing and 
chronic airflow limitation on one of the most 
clinically relevant issues, namely whether the 
effect of age on airflow resistance sensing remains 
a factor in COPD, or is exaggerated, or is over-rid-
den by the neuro-physiological consequences of 
persistently high airflow resistance. Our method 
for measuring LDT was developed to address the 
limitations of the bronchoconstriction methods 
[1]. A full review of the mechanisms determining 
resistance sensing are outside the scope of this 
paper, though the background physiology and 
related hypotheses have been covered in depth 
in our previous publications [1, 2, 7]. In short, 
detecting subjectively an increase in airflow 
resistance is the result of sensing that a change 
has occurred in the relation between inspiratory 
effort and the resulting tidal volume, an example 
of length-tension sensing [8–10]. The dynamic 
central monitoring of such breath-by-breath lung 
volume movements must depend on sensory in-
formation arising in thoracic mechano-receptors, 
including those located in the diaphragm, chest 
wall, airways and lung parenchyma. The dete-
rioration of proprioceptive acuity with age has 
been well documented for a number of functions 
such as postural sway, gaze stability and point 
relocation [11–16]. If an analogous change occurs 
in the accuracy and central processing of afferent 
mechano-receptor traffic from the diaphragm and 
chest wall it can be hypothesized that the resting 
LDT would rise progressively with age in patients 
above 55 years (the range within which most 
diagnosed COPD patients reside) and become 
more variable, as was observed in healthy people 
and asthmatics in remission [1, 2]. This was the 
primary hypothesis to be tested by the study pre-
sented in this paper. Therefore, we conducted an 
experiment to explore LDT in patients with COPD 
in relation to age and a number of other variab-
les of relevance in COPD including spirometric 
indices and smoking exposure.
Material and methods
Study design and subject selection
We conducted a prospective open cross-sec-
tional study. Patients with a diagnosis of COPD 
confirmed by pulmonologists using nationally 
agreed criteria [17] were invited to consent to 
participate. Potential participants were selected 
from a departmental diagnostic list. A prelimi-
nary powers calculation for comparing LDT be-
tween groups, based on a pilot study, indicated 
that from the 150 potential participants availa-
ble for the study, and assuming a population 
proportion of 50% and margin of error of 20%, 
a sample of 30 would be the minimum for sho-
wing significant difference with 95% confidence. 
The selection was quasi-random as all patients 
with COPD on the list were initially considered 
before application of the inclusion and exclusion 
criteria and all those who accepted the invitation 
to participate entered the study. The inclusion 
criteria were: adults with a diagnosis of COPD, 
at least 6 weeks since any exacerbation requiring 
an intervention and currently back to clinical 
baseline, abbreviated mental test (AMT) [18] 
above 7, willing to consent to take part in the 
study. The exclusion criteria were: contra-indi-
cations to performing spirometry (such as recent 
eye surgery), history of significant cognitive 
impairment or overt dementia (unlikely to be 
able to perform the tests) [19], currently taking 
any medication that can alter respiratory sensory 
function or cause sedation (such as opioids or 
benzodiazepines), any known or apparent cen-
tral or peripheral nervous system condition that 
might alter respiratory sensory function (such 
as stroke or sensory neuropathy), pulmonary 
co-morbidities that could alter the LDT (such 
as pulmonary fibrosis).
We also harvested LDT data from a study of 
normal people [1] to provide a comparison group 
across the same age range as the COPD study gro-
up and with approximately the same distribution 
of ages over the range. This was done after the 
COPD group had been recruited to enable the age 
range to be comparable. The normal group were 
all lifelong non-smokers, or ex-trivial smokers 
(< 1 pack-year), and all had normal spirometry 
indices and no history of respiratory disease or 
any other condition or medication that might alter 
their LDT measurements. They were all either 
university employees or staff and volunteers at 
our base hospital. 
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Measuring the LDT
We used exactly the same apparatus as in 
our previous studies of healthy people and asth-
matic patients [1, 2], constructed with standard 
respiratory physiology equipment (Harvard Ap-
paratus®). It was comprised of a flanged rubber 
mouthpiece connected to a unidirectional low 
resistance valve that was attached by a push-fit 
connector to an airflow resistor by a 90 cm section 
of low resistance respiratory tubing. The resistor 
could therefore be applied in either the inspira-
tory or expiratory mode. A disposable microbio-
logical filter (Vitalograph®) was inserted between 
the mouthpiece and valve. The dead space was 
less than 50 ml and did not vary. In preparatory 
experiments [1] it was found that a resistor aper-
ture of lentiform cross-sectional shape provided 
the most consistent and near-linear calibration 
curve over the flow range anticipated during ti-
dal breathing. Calibration of the resistor through 
its operational range was carried out with the 
resistor incorporated in the apparatus and using 
pumped air at 5 litres per minute at room tem-
perature (20–24 degrees centigrade) and ambient 
humidity, with flow determined by a bobbin flow 
meter (Rotameter®) and pressure by a water ma-
nometer using standard laboratory methods. In 
our previously published studies on volunteers 
willing to perform repeated LDT measurements 
we found a mean coefficient of variation of 4.3% 
in people under 65 years of age and 6.2% in those 
over 64 years of age (5 subjects performed 20 con-
secutive inspiratory LDT measurements in each 
group). We also found no significant differences 
between the LDT values of men and women when 
compared within young, middle aged and elderly 
age groups [1].
A detailed description of the LDT measure-
ment procedure we developed has been published 
elsewhere [1, 2] and it is recommended that rese-
archers wishing to construct a similar apparatus 
and to apply the technique should refer to those 
papers. In summary, LDT measurements were 
made in a quiet room with sources of distraction 
minimised. The patient was seated and requested 
to breathe tidally through the LDT apparatus 
wearing a nose clip and a pulse oximetry finger 
probe (Suaok® FS 10D). After a settling period 
of about 1 minute the resistor was closed, silen-
tly and out of sight, in half millimetre long-axis 
increments every 2 or 3 breath cycles until the 
subject indicated by raising a hand that they had 
reached the point at which they could first feel 
definite resistance to breathing. The aperture 
setting was recorded and later compared with the 
calibration curve to determine the measurement. 
Three such measurements were made in each 
of the inspiratory and expiratory modes. The 
means of the 3 readings were taken as the recor-
ded inspiratory and expiratory LDTs (ILDT and 
ELDT respectively). No readings were discarded. 
Corrections for actual temperature, humidity and 
atmospheric pressure were not made on indivi-
dual study days because they were found to be 
too small to be of significance.
Spirometry
Spirometry was performed on each parti-
cipant using a desktop spirometer (NDD Easy-
On-PC®). The ERS/ATS performance and inter-
pretation standards [16] for forced spirometry 
were applied and recordings were made of peak 
expiratory flow rate (PEF), forced expiratory vo-
lume in 1 second (FEV1) and forced vital capacity 
(FVC). Subjects unable to have these indices me-
asured to the required standard were not included 
in the data analysis. Height, weight, sex and age 
were recorded and used to calculate predicted 
values electronically using regional tables for 
Caucasians.
Study sequence
The order of data collection for each subject 
was: invitation and information, consent, AMT 
score, Medical Research Council Dyspnoea Scale 
(MRCDS) [20](used with permission of the Medi-
cal Research Council), record current medication, 
record clinical data (smoking history, sputum 
production and timing of last exacerbation), check 
inclusion and exclusion criteria, spirometry, LDT 
measurement. 
Statistical testing
Some continuous data were found to be 
approximately normally distributed on visual 
assessment, though this was not clear in all ca-
ses and the Shapiro Wilk test rendered values of 
< 0.05 in every case. Because of the uncertain 
distribution and small samples, groups were 
compared by the Mann Whitney U test. To take 
account of some outlying LDT data points in the 
relatively small samples correlation coefficients 
were calculated by the Spearman method, with 
the Bonferroni correction for multiple testing. 
For categorical data Fisher’s exact test was used 
to allow for the relatively small sample size. 
A significance level of 5% was adopted for group 
comparisons and correlations. All calculations 
were conducted using online software (socsci-
statistics.com). 
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Results
We studied 31 COPD patients (25 men, all 
Caucasian) with a mean age of 72 years (median 
77, range 55–89). All were smokers or ex-smokers 
with a mean exposure of 46 pack-years (range 
15–94). They were all clinically stable and at their 
usual baseline at the time of the study. Their re-
gular medication consisted of combined long-ac-
ting anti-muscarinic agent (LAMA), long-acting 
beta-adrenergic agonist (LABA) and corticosteroid 
(CS) by inhaler in 18 patients, LAMA plus LABA 
by inhaler in 3, CS plus either LAMA or LABA by 
inhaler in 6, LAMA alone by inhaler in 3 and no 
medication in 1. The mean AMTS was 9.5 (range 
8–10), MRCDS was 2.7 (range 1–5), FEV1 46% 
of predicted (range 23–59) and FEV1/FVC ratio 
47.3% (range 25.5–68.3). It was confirmed that 
all met the spirometry criteria for COPD [17]. 
The mean oxygen saturation at rest breathing air 
was of 95% (range 88–97) and none had a fall in 
oxygen saturation when having their LDTs me-
asured. Their mean body mass index (BMI) was 
26 kg/m2 (range 18.5–37.8).
The mean (SD) ILDT and ELDT values were 
5.93 (7.02) kPa.s/L (range 1.5–36) and 5.19 (5.20) 
kPa.s/L (range 1–27) respectively, with no signi-
ficant difference. Though the between-subject 
range was large there was close within-subject 
numerical concordance when comparing both 
indices (Figure 1) with a high degree of correlation 
(r = 0.959, p < 0.001) and the line of regression 
through the points was close to the line of identity 
between the axes, indicating an absence of tidal 
phase bias. Correlations between ILDT, ELDT and 
other variables are shown in Table 1. There was 
no significant correlation between ILDT and age 
(Figure 2), FEV1, FVC, PEF, height, BMI, oxygen 
saturation and smoking pack-years. However, the-
re was significant correlation between ILDT and 
FEV1/FVC and between ELDT and FEV1/FVC. No 
significant correlations with ILDT or ELDT emer-
ged when FEV1, FVC and PEF were expressed as 
percentages of the predicted values derived from 
age, height, BMI and sex. The mean (SD) ILDT of 
patients who produced sputum on most days (N 
= 18) was 5.64 (5.14) kPa.s/L and that of those 
Table 1. Coefficients of correlation (r) and probability 
values (P) for ILDT and ELDT compared with 
a number of variables. (Spearman method, 
N=31).
R P R P
Age -0.182 0.326 -0.164 0.377
FEV1 0.072 0.710 0.088 0.690
FVC 0.154 0.410 0.161 0.440
PEF 0.004 0.989 0.008 0.991
FEV1/FVC 0.367 0.048* 0.481 0.007*
Height -0.322 0.130 -0.299 0.111
Weight 0.200 0.301 0.223 0.341
BMI -0.099 0.616 -0.104 0.625
Oxygen  
saturation
0.232 0.294 0.244 0.317
Smoking 
pack-years
0.019 0.966 0.023 0.974
BMI — body mass index; ; ELDT — expiratory airflow resistance load detection 
threshold;  FEV1 — forced expiratory volume in 1 second; FVC — forced vital 
capacity; ILDT — inspiratory airflow resistance load detection threshold; PEF 
— peak expiratory flow rate
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Figure 1.  Correlation of ILDT with ELDT for COPD patients (N = 
31, r = 0.959, P > 0.001, Spearman method). The line of identity 
between the axes is shown. ILDT — inspiratory airflow resistance 
load detection threshold; ELDT — expiratory airflow resistance load 
detection threshold
Figure 2. No significant correlation was found between ILDT and age 
in COPD patients (N = 31, r = -0.182, P = 0.326, Spearman method). 
ILDT — inspiratory airflow resistance load detection threshold
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who produced sputum occasionally or never (N 
= 13) was 6.51 (9.32) kPa.s/L and there was no 
significant difference (p = 0.781) . 
In the healthy comparison group (N = 60, 
25 men, all Caucasian), the mean age was 70 years 
(median 74, range 55–86). The mean FEV1 was 
98% of predicted (range 86–117) and the mean 
FEV1/FVC ratio was 77% (range 72 – 81) and was 
between 94 – 112% of predicted and thereby 
within the normal range for men and women. 
Their mean BMI was 27.0 kg/m2 (range 21.0–36.5), 
all had an AMT score of 10 and MRCDS score of 
0. There were no significant differences in the 
ages or BMIs of the COPD and healthy groups 
(P = 0.253 and P = 0.304 respectively), though 
there was a significantly higher proportion of 
women in the healthy group (P = 0.05). The 
mean (SD) ILDT was 11.11 (8.47) kPa.s/L which 
was significantly higher than in the COPD group 
(P = 0.005). In the healthy subjects a significant 
positive correlation was found between ILDT and 
age across the comparison age range (r = 0.589, 
P < 0.001)
The findings for ELDT were very similar for 
all comparisons. 
Discussion
The findings of the study did not confirm the 
hypothesis we set out to test. On the contrary, we 
found that the mean LDTs in patients with COPD 
were lower rather than higher than those of the 
older healthy comparison group within the same 
age range in this study and very similar to the 
young and middle-aged healthy subjects in our 
previous study [1]. Further, there was no apparent 
tendency for LDTs to rise with age in the COPD 
group, unlike healthy control patients, across the 
55 to 85 age range. There must be some caution 
in drawing any firm conclusions from these data, 
particularly the correlative relationships, because 
the sample was relatively small and the levels of 
statistical significance, or lack thereof, must be 
interpreted in the light of that limitation. Never-
theless, in group comparisons the clearly signifi-
cantly lower mean LDT values in COPD patients 
compared to healthy people in the same age range 
is noteworthy. It appears that the physiological 
burden of chronically raised airways resistance 
does not have a blunting or down-regulatory ef-
fect on the ability to detect subjectively a rise in 
airflow resistance in COPD. Indeed, there appears 
to be preservation of that ability across an older 
age range in COPD in contrast to healthy people 
and asthmatics in remission [1, 2]. The reasons 
for this observation are not clear. It is known that 
people with COPD breathe with an exaggerated 
intrathoracic pressure swing between inspiration 
and expiration and at a higher and less mecha-
nically advantageous lung volume [21] so it can 
be postulated that they could be predisposed to 
finer detection of perturbations in length-tension 
cycles during tidal breathing and thereby con-
serve LDT detection sensitivity into old age. If 
that were a contributary mechanism it might be 
expected that LDTs would rise in line with the 
FEV1/FVC ratio as those with higher ratios can 
arguably be considered to have less impairment 
of respiratory mechanics. We found such a rise 
that was of borderline statistical significance for 
ILDT though more clearly significant for ELDT. 
This supports the rationale described, though the 
number of participants was probably too low to 
comment on that aspect with certainty. Further, 
the unexpected negative correlation we found 
between LDTs and age might also be due to the 
deterioration in lung and chest wall mechanics 
over time in people with COPD, which might 
consequently eclipse the effects of ageing that 
we found in healthy subjects in this study and 
in previous work [1, 2]. Again, the small sample 
size, which was probably insufficiently powered 
for that particular part of the analysis precludes 
a firm conclusion. However, the trend makes phy-
siological sense and needs to the specific focus of 
another study. The age and BMI characteristics 
of the groups were comparable so it is unlikely 
that those variables could account for the diffe-
rences we observed. There was a significantly 
larger proportion of women in the healthy group. 
However, in our previous work [1, 2] we found 
no differences in the pattern of the relationship 
between ILDT and age between men and women, 
and that also appeared to be the case on scrutiny 
of the distribution of measurements in this study, 
though the samples were too small for confident 
statistical analysis. 
In healthy people and patients with COPD the 
detection thresholds were below the resistance 
levels that we found to be distressing or uncom-
fortable in young and middle-aged healthy sub-
jects who took part in our preliminary resistance 
ranging studies [1]. However, it is not known 
whether the afferent input from chest wall and 
diaphragmatic mechano-receptors has a linear 
influence on central length-tension processing. 
If not, it can be argued that the small additional 
resistances used when testing for LDT would 
have a proportionally larger central effect for 
COPD patients already tidally breathing at higher 
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lung volumes against chronically raised airflow 
resistance and greater recoil forces, thus allowing 
an alternative explanation for our observations to 
be posited. There is not complete agreement as to 
whether external airflow resistance loading is a va-
lid analogue for intrinsic airways resistance, though 
it has been acknowledged that mechano-receptors 
must be involved [22]. The role of afferent sensory 
traffic from airway and lung parenchymal receptors 
[23] does not appear to be dominant in normal 
subjects, though could be more contributary to de-
termining the sensitivity of central length-tension 
processing in those with lung disease, including 
COPD [24]. However, it has been observed that lung 
transplant patients, who have denervated lungs 
but intact chest wall and diaphragmatic sensation, 
retain the ability to judge lung volumes and have 
normal sensitivity to changes in external airflow 
resistance [25–27], which reinforces the key role 
of the mechano-receptors in the skeleto-muscu-
lar structures in airflow resistance sensing. The 
findings of our previous studies of healthy people 
and well-controlled asthmatics suggested that an 
age-related reduction in the sensitivity of airflow re-
sistance sensing could be at least partly responsible 
for the clinically observed reduction in the ability of 
elderly people to detect early the changes in airflow 
resistance that occur, for example, in a worsening of 
asthma. However, the same does not seem to be the 
case for patients with COPD who appear to retain 
an acuity of airflow resistance sensing that is more 
typical of young adults. 
There are clinical implications to the findings 
of this study. Our findings suggest that patients 
with COPD who are not undergoing an exacerba-
tion are likely to be able to detect a rise in their 
airway resistance with a high degree of acuity 
at any age. Therefore, the concern that elderly 
COPD patients might delay taking reliever inhaled 
broncho-dilator therapy, or present later to medi-
cal services for help during an exacerbation due 
to ageing effects on resistance sensing is refuted, 
unlike some elderly asthmatics. It is apparently 
therefore not necessary to advocate that the COPD 
treatment guidelines [17] need take account of age 
for that specific reason. Of course, elderly patients 
with COPD do have a higher prevalence of other 
factors that complicate their management, such 
as dementia and heart failure, which must be 
acknowledged in their treatment plans. 
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